Ascendis Pharma A/S - American Depositary Shares (ASND)

CUSIP: 04351P101

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Equity / American Depositary Shares
Shares outstanding
61,990,867
Total 13F shares
30,513,340
Share change
+1,197,005
Total reported value
$1,222,363,447
Price per share
$40.06
Number of holders
64
Value change
+$50,139,269
Number of buys
36
Number of sells
27

Security key

04351P101

Report period

Q4 2017

Institutions

64

Top holders

10

Top shareholders of ASND - Ascendis Pharma A/S - American Depositary Shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
RA CAPITAL MANAGEMENT, L.P.
13F
Company
9%
5,580,690
$202,300,000 30 Sep 2017
13F
FMR LLC
13F
Company
5.9%
3,630,224
$131,596,000 30 Sep 2017
13F
ORBIMED ADVISORS LLC
13F
Company
5.4%
3,367,315
$122,065,000 30 Sep 2017
13F
BAKER BROS. ADVISORS LP
13F
Company
3.8%
2,348,840
$85,145,000 30 Sep 2017
13F
EcoR1 Capital, LLC
13F
Company
3.4%
2,107,600
$76,401,000 30 Sep 2017
13F
Vivo Capital, LLC
13F
Company
2.9%
1,766,832
$64,048,000 30 Sep 2017
13F
Avoro Capital Advisors LLC
13F
Company
2.6%
1,636,124
$59,309,000 30 Sep 2017
13F
VHCP Management II, LLC
13F
Company
2.1%
1,299,052
$47,091,000 30 Sep 2017
13F
EVENTIDE ASSET MANAGEMENT, LLC
13F
Company
1.9%
1,204,540
$43,665,000 30 Sep 2017
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
1.4%
850,000
$30,813,000 30 Sep 2017
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.83%
512,414
$18,575,000 30 Sep 2017
13F
ACUTA CAPITAL PARTNERS, LLC
13F
Company
0.81%
500,000
$18,125,000 30 Sep 2017
13F
Marshall Wace North America L.P.
13F
Company
0.73%
454,485
$16,361,000 30 Sep 2017
13F
FIRST MANHATTAN CO. LLC.
13F
Company
0.57%
355,348
$12,881,000 30 Sep 2017
13F
OppenheimerFunds, Inc.
13F
Company
0.48%
297,360
$10,779,000 30 Sep 2017
13F
Foresite Capital Management III, LLC
13F
Company
0.46%
285,143
$10,336,000 30 Sep 2017
13F
Laurion Capital Management LP
13F
Company
0.46%
283,330
$10,271,000 30 Sep 2017
13F
Rock Springs Capital Management LP
13F
Company
0.45%
280,000
$10,150,000 30 Sep 2017
13F
LORD, ABBETT & CO. LLC
13F
Company
0.42%
258,653
$9,376,000 30 Sep 2017
13F
JPMORGAN CHASE & CO
13F
Company
0.33%
201,781
$7,163,000 30 Sep 2017
13F
Ghost Tree Capital, LLC
13F
Company
0.32%
200,000
$7,250,000 30 Sep 2017
13F
SPHERA FUNDS MANAGEMENT LTD.
13F
Company
0.21%
129,474
$4,693,000 30 Sep 2017
13F
Allianz Asset Management GmbH
13F
Company
0.19%
120,450
$4,366,000 30 Sep 2017
13F
Hudson Bay Capital Management LP
13F
Company
0.19%
120,000
$4,350,000 30 Sep 2017
13F
Alyeska Investment Group, L.P.
13F
Company
0.18%
110,000
$3,988,000 30 Sep 2017
13F
DRIEHAUS CAPITAL MANAGEMENT LLC
13F
Company
0.16%
99,328
$3,601,000 30 Sep 2017
13F
DEUTSCHE BANK AG\
13F
Company
0.15%
92,680
$3,358,000 30 Sep 2017
13F
DAFNA Capital Management LLC
13F
Company
0.12%
72,226
$2,618,000 30 Sep 2017
13F
MORGAN STANLEY
13F
Company
0.11%
67,332
$2,441,000 30 Sep 2017
13F
EMORY UNIVERSITY
13F
Company
0.1%
59,876
$2,171,000 30 Sep 2017
13F
Magnetar Financial LLC
13F
Company
0.06%
38,985
$1,413,000 30 Sep 2017
13F
HBK INVESTMENTS L P
13F
Company
0.06%
35,000
$1,269,000 30 Sep 2017
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.05%
33,500
$1,214,000 30 Sep 2017
13F
ALPS ADVISORS INC
13F
Company
0.05%
31,929
$1,157,000 30 Sep 2017
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.05%
30,076
$1,090,000 30 Sep 2017
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.05%
30,000
$1,088,000 30 Sep 2017
13F
Iguana Healthcare Management, LLC
13F
Company
0.05%
30,000
$1,088,000 30 Sep 2017
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.03%
19,972
$723,000 30 Sep 2017
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.03%
19,658
$713,000 30 Sep 2017
13F
STATE STREET CORP
13F
Company
0.03%
18,752
$679,000 30 Sep 2017
13F
Endurant Capital Management LP
13F
Company
0.03%
17,330
$628,000 30 Sep 2017
13F
Maven Securities LTD
13F
Company
0.03%
16,757
$610,000 30 Sep 2017
13F
CITADEL ADVISORS LLC
13F
Company
0.02%
10,273
$372,000 30 Sep 2017
13F
Schonfeld Strategic Advisors LLC
13F
Company
0.02%
9,763
$354,000 30 Sep 2017
13F
JANE STREET GROUP, LLC
13F
Company
0.02%
9,704
$352,000 30 Sep 2017
13F
Trexquant Investment LP
13F
Company
0.01%
8,832
$320,000 30 Sep 2017
13F
Matisse Capital
13F
Company
0.01%
8,590
$311,000 30 Sep 2017
13F
Aperio Group, LLC
13F
Company
0.01%
6,659
$241,000 30 Sep 2017
13F
BlueCrest Capital Management Ltd
13F
Company
0.01%
6,245
$226,000 30 Sep 2017
13F
TUDOR INVESTMENT CORP ET AL
13F
Company
0.01%
5,918
$215,000 30 Sep 2017
13F

Institutional Holders of Ascendis Pharma A/S - American Depositary Shares (ASND) as of Q4 2017

As of 31 Dec 2017, Ascendis Pharma A/S - American Depositary Shares (ASND) was held by 64 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 30,513,340 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, LLC, FMR LLC, ORBIMED ADVISORS LLC, BAKER BROS. ADVISORS LP, EcoR1 Capital, LLC, Vivo Capital, LLC, venBio Select Advisor LLC, EVENTIDE ASSET MANAGEMENT, LLC, VHCP Management II, LLC, and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C). This page lists 64 institutional shareholders reporting positions in this security for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2017 vs Q3 2017 Across Filers

Q3 2017 holders
59
Q4 2017 holders
64
Holder diff
5
Investor Q3 2017 Shares Q4 2017 Shares Share Diff Share Chg % Q3 2017 Value $ Q4 2017 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .